Physician profile
John D Bennett
NPI 1396703401
$309.20
in general payments reported to CMS, 2019-2025
9 companies · $14.13 in 2025
The $14.13 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.59 · 2020: $20.18 · 2021: $100 · 2022: $63.77 · 2023: $47.59 · 2024: $47.63 · 2025: $14.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $100.31 | 2021 | |
| Supernus Pharmaceuticals, INC. | $47.59 | 2023 | Qelbree |
| Merck Sharp & Dohme LLC | $40.27 | 2022-2024 | Bridion |
| Mindray Ds USA, INC. | $29.29 | 2024 | A7 Anesthesia System |
| Impel Pharmaceuticals INC. | $21.08 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.76 | 2022 | |
| Covidien Lp | $20.18 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $15.59 | 2019 | |
| Tris Pharma INC | $14.13 | 2025 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.